drugset / Trial / NCT02414048
Hypoxia Analysis in Head and/or Neck Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The primary objective is the prospective determination of disease-specific and overall survival in head and neck cancer patients who have undergone surgery, correlated to non-invasive methods of measuring tumour hypoxia. The secondary objective is to define tumour hypoxia using non-invasive methodology.
Timeline
- Start
- 2015-04
- Primary completion
- 2022-10
- Completion
- 2022-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pimonidazole | Diagnostic / imaging agent | — | Oral |